Oklo

Oklo reports that its Groves isotope test reactor has achieved initial criticality after initiating a controlled, low-power, self-sustaining chain reaction. The milestone came less than a year after groundbreaking and concerns the first reactor in the DOE reactor pilot program to be built from the ground up on private land. The project aims to strengthen domestic isotope production and provided experience in construction, operation, fuel procurement, and safety and qualification work. » More on de.investing.com

Oklo has received approval from the U.S. Department of Energy to load nuclear fuel and begin operation of its Groves isotope test reactor. The project, approved under the DOE Reactor Pilot Program, demonstrates reactor operation for planned domestic isotope production for medicine, industry, research, spaceflight and national security. The approval follows a successful readiness review and covers construction, personnel qualification, procurement of fuel and equipment, and implementation of operational and safety programs. » More on de.investing.com

Analysts' median one-year price target for Oklo is $87, implying roughly 112% upside from the July 16 close, with the most bullish target at $140. Oklo remains pre-revenue but is developing vertically integrated reactors and fuel recycling capabilities and held $2.5 billion in cash and marketable securities as of March 31. The article notes significant upside potential but warns investors to weigh short-term revenue absence and suggests a longer time horizon may improve risk‑reward. » More on finance.yahoo.com